North American advocacy groups and local organizers have designated June as Scleroderma Awareness Month to support those living with the autoimmune disease.

This designation aims to increase public visibility for a condition that often lacks widespread recognition, facilitating better patient support and funding for medical research.

Community efforts have spanned multiple regions, including specific events in Leadville, Colorado, and Orangeville, Ontario [1, 2]. Local officials in Leadville worked with organizers to recognize the month, while the community in Ontario focused on financial contributions to the cause.

In Orangeville, a Scleroderma Awareness Walk exceeded its initial fundraising goals by raising $12,000 [3]. These funds are intended to assist individuals battling the disease and to accelerate the search for a cure.

The month-long observance culminates in a specific day of action. June 29 is recognized as Scleroderma Awareness Day [2]. This date serves as a focal point for global outreach and education about the symptoms and challenges associated with the disease.

Organizers such as Make a Move for Scleroderma continue to coordinate walks and proclamations to ensure the disease remains in the public eye [1, 2]. These activities help patients feel less isolated by building a visible network of community support.

Public health officials and advocacy groups said the goal is to move toward a future where early diagnosis and effective treatments are accessible to all patients [1, 4].

“June is Scleroderma Awareness Month”

The formalization of June as an awareness month and the designation of June 29 as a specific day of action signal a shift toward organized, grassroots advocacy for rare autoimmune diseases. By combining local government proclamations with tangible fundraising successes, such as the event in Ontario, advocacy groups are creating a scalable model to increase research funding and patient visibility.